• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911412220
Device Problem Occlusion Within Device (1423)
Patient Problems Angina (1710); Reocclusion (1985)
Event Date 12/19/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2017-13368.(b)(6) study.It was reported that in-stent restenosis (isr) and angina occurred.In (b)(6) 2013, clinical status assessment indicated that the patient¿s qualifying condition was stable angina.The patient was noted to have abnormal stress test or imaging stress test indicative of ischemia and was referred for elective cardiac catheterization.Target lesion #1 was located in the mid left anterior descending (lad) artery with 80% stenosis and was 22mm long with a reference vessel diameter of 3mm.The target lesion #1 was treated with pre-dilatation and placement of a 3.0 x 28mm study stent with 0% residual stenosis.Target lesion #2 was located in the 1st diagonal with 95% stenosis and was 6mm long with a reference vessel diameter of 2.25mm.The target lesion #2 was treated with pre-dilatation and placement of a 2.25 x 12mm study stent with 0% residual stenosis.Target lesion #3 was located in 1st right posterolateral (rpl) with 90% stenosis and was 6mm long with a reference vessel diameter of 2.5mm.The target lesion #3 was treated with pre-dilatation and placement of a 2.50 x 12mm study stent with 0% residual stenosis.On the following day, the patient was discharged on dual antiplatelet therapy.In (b)(6) 2017, the patient presented as an outpatient with complaints of chest discomfort and severe fatigue, dyspnea.The patient complained that he was not feeling well in the last few weeks and eventually progression of coronary artery disease (cad) and possible stent restenosis was suspected.The patient was recommended for ischemic evaluation.On that same day, the patient's electrocardiogram (ekg) revealed sinus rhythm, non-specific st changes, low voltages, old inferior myocardial infarction (mi) with q waves.The patient was advised to continue with his medications asa, lopressor, imdur and plavix.Two days after, the 70-80% stenosis in the proximal and mid portion of the lad was treated with a 2.5 x 33mm non-bsc drug-eluting stent (des).Following post-dilatation, residual stenosis was 0%.Additionally, the 80-90% stenosis in the 2nd diagonal was treated with placement of a 2.5 x 8mm non-bsc des.Following post-dilatation, residual stenosis was 0%.On that same day, 80% stenosis in the proximal lcx was treated with placement of a 2.0 x 15mm non-bsc des.Following post-dilatation residual stenosis was 0%.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7394724
MDR Text Key104248399
Report Number2134265-2018-03336
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 03/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/14/2013
Device Model NumberH7493911412220
Device Catalogue Number39114-1222
Device Lot Number15689423
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/09/2018
Initial Date FDA Received04/03/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age62 YR
-
-